Viracta Therapeutics Inc (VIRX)
0.8299
+0.02
(+2.44%)
USD |
NASDAQ |
May 17, 16:00
0.8299
0.00 (0.00%)
After-Hours: 20:00
Viracta Therapeutics Price to Book Value: 5.631 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 5.631 |
| May 16, 2024 | 5.653 |
| May 15, 2024 | 5.862 |
| May 14, 2024 | 5.610 |
| May 13, 2024 | 5.380 |
| May 10, 2024 | 5.303 |
| May 09, 2024 | 5.757 |
| May 08, 2024 | 5.729 |
| May 07, 2024 | 5.722 |
| May 06, 2024 | 5.583 |
| May 03, 2024 | 5.654 |
| May 02, 2024 | 5.862 |
| May 01, 2024 | 5.723 |
| April 30, 2024 | 5.719 |
| April 29, 2024 | 5.729 |
| April 26, 2024 | 5.780 |
| April 25, 2024 | 5.910 |
| April 24, 2024 | 5.836 |
| April 23, 2024 | 5.916 |
| April 22, 2024 | 6.141 |
| April 19, 2024 | 5.978 |
| April 18, 2024 | 6.343 |
| April 17, 2024 | 6.533 |
| April 16, 2024 | 4.988 |
| April 15, 2024 | 5.443 |
| Date | Value |
|---|---|
| April 12, 2024 | 8.025 |
| April 11, 2024 | 8.164 |
| April 10, 2024 | 7.955 |
| April 09, 2024 | 7.397 |
| April 08, 2024 | 7.466 |
| April 05, 2024 | 7.118 |
| April 04, 2024 | 7.257 |
| April 03, 2024 | 7.606 |
| April 02, 2024 | 7.606 |
| April 01, 2024 | 7.746 |
| March 28, 2024 | 3.113 |
| March 27, 2024 | 3.296 |
| March 26, 2024 | 3.296 |
| March 25, 2024 | 3.235 |
| March 22, 2024 | 2.961 |
| March 21, 2024 | 3.266 |
| March 20, 2024 | 3.449 |
| March 19, 2024 | 3.083 |
| March 18, 2024 | 3.022 |
| March 15, 2024 | 3.04 |
| March 14, 2024 | 2.961 |
| March 13, 2024 | 2.900 |
| March 12, 2024 | 3.006 |
| March 11, 2024 | 2.717 |
| March 08, 2024 | 2.595 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6905
Minimum
Dec 19 2023
8.164
Maximum
Apr 11 2024
2.052
Average
1.611
Median
Nov 23 2022
Price to Book Value Benchmarks
| XOMA Corp | 3.608 |
| Organovo Holdings Inc | 1.673 |
| Marinus Pharmaceuticals Inc | -- |
| Cartesian Therapeutics Inc | -- |
| Adial Pharmaceuticals Inc | 1.539 |
Price to Book Value Related Metrics
| Price | 0.8299 |
| Earnings Yield | -152.4% |
| Market Cap | 31.69M |